4th AMR Conference 2020
Digital conference week 24–28 August 2020
What was different for the AMR Conference 2020?
In view of the continuing uncertain situation and travel restrictions due to the COVID-19 pandemic, we implemented the 4th AMR Conference as a digital format in the week of 24–28 August 2020.
The global health crisis caused by COVID-19 shows more than ever the importance of infectious diseases expertise and the high need for further fighting against antimicrobial resistance (AMR). A cross-sectoral international dialogue with all stakeholders involved will be crucial to help implement innovative therapies and diagnostics in the clinical practice globally.
Together with our supporters – among others our major partner, the BEAM Alliance – the AMR Conference will continue to provide a (virtual) platform for those debates bringing together stakeholders from industry, SMEs, start-ups, academia, clinics, investors, public institutions and policy. Within our digital AMR Conference Week in August, we caught up discussing the challenges of bringing new antimicrobial treatments and diagnostics into the market.
Five days of insights and networking for the global AMR community: Each conference day covered a focus topic with selected LIVE sessions and high-level panels. Additionally, participants were able to explore scientific poster presentations, participate in virtual 1:1 meetings throughout the whole week and to engage within our new digital AMR stakeholder platform.
Here are some key takeaways from the Closing Session:
Highlights – Digital AMR Conference 2020
- Lessons learned from COVID-19
- Business models & policy incentives
- Global markets
- Financing & investing
- Outlook & roadmap
- Focus on therapeutics
- Focus incentives, reimbursement, regulatory aspects and markets
- Focus on animal health
- Focus on diagnostics
- Start-up pitches
- SME Campus (therapeutics and diagnostics)